Novavax Inc
NVAX
Revenue
415.48M
▲321.63M▲342.69%
3 Months ChangeAssets
1.82B
▲465.11M▲34.36%
3 Months ChangeLiabilities
2.25B
▲29.73M▲1.34%
3 Months ChangeFree Cash Flow
-105.34M
▼-754.64M▼-116.22%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-16
Form 8-K
ID: 0001104659-24-108950
2024-10-03
Form 8-K
ID: 0001104659-24-105533
2024-08-08
Form 8-K
ID: 0001000694-24-000037
2024-08-08
Form 10-Q
ID: 0001000694-24-000035
2024-06-14
Form 8-K
ID: 0001104659-24-071735
2024-06-06
Form 8-K
ID: 0001104659-24-068875
2024-05-23
Form 8-K
ID: 0001104659-24-064680
2024-05-13
Form 8-K
ID: 0001104659-24-060444
2024-05-10
Form 8-K
ID: 0001104659-24-059659
2024-05-10
Form 10-Q
ID: 0001000694-24-000031